At the just-completed CDC Grand Rounds, Dr. Avindra Nath of NINDS spoke fairly quickly and he presented a lot of details. I didn't take good notes, so others should fill in.
- NIH will do a 3 phase study, starting with observation (the first study w/ 40+ patients) through treatment
- Immune...